These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 27109813)

  • 1. Post-tuberculous lung function impairment in a tuberculosis reference clinic in Cameroon.
    Mbatchou Ngahane BH; Nouyep J; Nganda Motto M; Mapoure Njankouo Y; Wandji A; Endale M; Afane Ze E
    Respir Med; 2016 May; 114():67-71. PubMed ID: 27109813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary Impairment in Tuberculosis Survivors: The Korean National Health and Nutrition Examination Survey 2008-2012.
    Jung JW; Choi JC; Shin JW; Kim JY; Choi BW; Park IW
    PLoS One; 2015; 10(10):e0141230. PubMed ID: 26496500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in respiratory function impairment following the treatment of severe pulmonary tuberculosis - limitations for the underlying COPD detection.
    Radovic M; Ristic L; Ciric Z; Dinic-Radovic V; Stankovic I; Pejcic T; Rancic M; Bogdanovic D
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1307-16. PubMed ID: 27366058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced lung function and health-related quality of life after treatment for pulmonary tuberculosis in Gambian children: a cross-sectional comparative study.
    Nkereuwem E; Agbla S; Sallahdeen A; Owolabi O; Sillah AK; Genekah M; Tunkara A; Kandeh S; Jawara M; Saidy L; Bush A; Togun T; Kampmann B
    Thorax; 2023 Mar; 78(3):281-287. PubMed ID: 36109164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPD.
    Gupte AN; Paradkar M; Selvaraju S; Thiruvengadam K; Shivakumar SVBY; Sekar K; Marinaik S; Momin A; Gaikwad A; Natrajan P; Prithivi M; Shivaramakrishnan G; Pradhan N; Kohli R; Raskar S; Jain D; Velu R; Karthavarayan B; Lokhande R; Suryavanshi N; Gupte N; Murali L; Salvi S; Checkley W; Golub J; Bollinger R; Mave V; Padmapriyadarasini C; Gupta A
    PLoS One; 2019; 14(5):e0217289. PubMed ID: 31120971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of pulmonary function impairments in patients with mucopolysaccharidoses--changes with age and treatment.
    Lin SP; Shih SC; Chuang CK; Lee KS; Chen MR; Niu DM; Chiu PC; Lin SJ; Lin HY
    Pediatr Pulmonol; 2014 Mar; 49(3):277-84. PubMed ID: 23401495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Airflow obstruction and small airway dysfunction following pulmonary tuberculosis: a cross-sectional survey.
    Xing Z; Sun T; Janssens JP; Chai D; Liu W; Tong Y; Wang Y; Ma Y; Pan M; Cui J; Wang C; Guo Y
    Thorax; 2023 Mar; 78(3):274-280. PubMed ID: 35361688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of low forced expiratory flow between 25% and 75% of vital capacity following treated pulmonary tuberculosis: a cross-sectional study.
    Pefura-Yone EW; Kengne AP; Tagne-Kamdem PE; Afane-Ze E
    BMJ Open; 2014 Jul; 4(7):e005361. PubMed ID: 25056978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory symptoms and lung function in patients treated for pulmonary tuberculosis in Malawi: a prospective cohort study.
    Nightingale R; Chinoko B; Lesosky M; Rylance SJ; Mnesa B; Banda NPK; Joekes E; Squire SB; Mortimer K; Meghji J; Rylance J
    Thorax; 2022 Nov; 77(11):1131-1139. PubMed ID: 34937802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spirometric abnormalities following treatment for pulmonary tuberculosis in Ilorin, Nigeria.
    Ojuawo OB; Fawibe AE; Desalu OO; Ojuawo AB; Aladesanmi AO; Opeyemi CM; Adio MO; Salami AK
    Niger Postgrad Med J; 2020; 27(3):163-170. PubMed ID: 32687114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study.
    Meghji J; Lesosky M; Joekes E; Banda P; Rylance J; Gordon S; Jacob J; Zonderland H; MacPherson P; Corbett EL; Mortimer K; Squire SB
    Thorax; 2020 Mar; 75(3):269-278. PubMed ID: 32102951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung functions among patients with pulmonary tuberculosis in Dar es Salaam - a cross-sectional study.
    Manji M; Shayo G; Mamuya S; Mpembeni R; Jusabani A; Mugusi F
    BMC Pulm Med; 2016 Apr; 16(1):58. PubMed ID: 27107713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for chronic lung impairment in patients treated for pulmonary tuberculosis.
    Vecino M; Pasipanodya JG; Slocum P; Bae S; Munguia G; Miller T; Fernandez M; Drewyer G; Weis SE
    J Infect Public Health; 2011 Nov; 4(5-6):244-52. PubMed ID: 22118719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual lung damage after completion of treatment for multidrug-resistant tuberculosis.
    de Vallière S; Barker RD
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):767-71. PubMed ID: 15182148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary function and respiratory health after successful treatment of drug-resistant tuberculosis.
    Vashakidze SA; Kempker JA; Jakobia NA; Gogishvili SG; Nikolaishvili KA; Goginashvili LM; Magee MJ; Kempker RR
    Int J Infect Dis; 2019 May; 82():66-72. PubMed ID: 30844519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in lung function according to disease extent before and after pulmonary tuberculosis.
    Ko Y; Lee YM; Lee HY; Lee YS; Song JW; Hong GY; Kim MY; Lee HK; Choi SJ; Shim EJ
    Int J Tuberc Lung Dis; 2015 May; 19(5):589-95. PubMed ID: 25868029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How accurate is spirometry at predicting restrictive pulmonary impairment?
    Aaron SD; Dales RE; Cardinal P
    Chest; 1999 Mar; 115(3):869-73. PubMed ID: 10084506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.
    Majumdar S; Sen S; Mandal SK
    J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of antimicrobial chemotherapy on spirometric parameters and pro-inflammatory indices in severe pulmonary tuberculosis.
    Plit ML; Anderson R; Van Rensburg CE; Page-Shipp L; Blott JA; Fresen JL; Feldman C
    Eur Respir J; 1998 Aug; 12(2):351-6. PubMed ID: 9727784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary impairment after tuberculosis.
    Pasipanodya JG; Miller TL; Vecino M; Munguia G; Garmon R; Bae S; Drewyer G; Weis SE
    Chest; 2007 Jun; 131(6):1817-24. PubMed ID: 17400690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.